source
- Recon: FDA orders new eye risk warnings for Ozempic, Zepbound; FDA launches investigation of Novartis’ Zolgensma after cancer ca...Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 23h ago↗ source
- Asia-Pacific Roundup: India proposes immediate license suspensions for manufacturers of substandard drugsThe Indian government has proposed immediately suspending the license of any company that produces a drug that is not of standard quality.raps · 23h ago↗ source
- FDA slashes number of analytical tests for IVDs used in public health emergenciesThe US Food and Drug Administration (FDA) on Monday finalized guidance to assist manufacturers in validating in vitro diagnostic devices (IVDs) that test for emerging pathogens during public health…